Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 1900 2022-09-13 11:06:55 |
2 format correct Meta information modification 1900 2022-09-14 03:27:02 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
D’archivio, M.;  Santangelo, C.;  Silenzi, A.;  Scazzocchio, B.;  Varì, R.;  Masella, R. Dietary EVOO Polyphenols and Gut Microbiota Interaction. Encyclopedia. Available online: (accessed on 21 April 2024).
D’archivio M,  Santangelo C,  Silenzi A,  Scazzocchio B,  Varì R,  Masella R. Dietary EVOO Polyphenols and Gut Microbiota Interaction. Encyclopedia. Available at: Accessed April 21, 2024.
D’archivio, Massimo, Carmela Santangelo, Annalisa Silenzi, Beatrice Scazzocchio, Rosaria Varì, Roberta Masella. "Dietary EVOO Polyphenols and Gut Microbiota Interaction" Encyclopedia, (accessed April 21, 2024).
D’archivio, M.,  Santangelo, C.,  Silenzi, A.,  Scazzocchio, B.,  Varì, R., & Masella, R. (2022, September 13). Dietary EVOO Polyphenols and Gut Microbiota Interaction. In Encyclopedia.
D’archivio, Massimo, et al. "Dietary EVOO Polyphenols and Gut Microbiota Interaction." Encyclopedia. Web. 13 September, 2022.
Dietary EVOO Polyphenols and Gut Microbiota Interaction

Accumulating evidence indicates that regular consumption of extra virgin olive oil (EVOO), the main source of fat in the Mediterranean diet, is associated with beneficial health effects and a reduced risk of developing chronic degenerative disorders. The beneficial effects of EVOO can be attributed to its unique composition in monounsaturated fats and phenolic compounds that provide important antioxidant, anti-inflammatory, and immune-modulating activities. On the other hand, it is well known that the gut microbiota has several important roles in normal human physiology, and its composition can be influenced by a multitude of environmental and lifestyle factors, among which dietary components play a relevant role.

extra virgin olive oil polyphenols gut microbiota sex gender diet

1. Introduction

The beneficial effects of polyphenols contained in extra virgin olive oil (EVOO) have been recognized by the European Food Safety Authority, which recommends a daily consumption of about 20 g of EVOO, containing at least 5 mg of hydroxytyrosol (HT) and its derivatives, to prevent the onset of cardiovascular disease (CVD) and inflammation and to counteract oxidative stress caused by free radicals [1]. Encouraging findings indicate that obesity, metabolic and digestive disorders, liver and neurological diseases, and cancer can also benefit from EVOO polyphenol ingestion [2], as demonstrated by the increasing number of clinical trials designed to understand and validate the benefits of EVOO and its polyphenols in human diseases, as seen in the public web archive of (accessed on 30 April 2022).
EVOO polyphenols exert their well-known health benefits by interacting with fundamental cell signaling and gene regulation pathways in target cells and tissues. These compounds, after ingestion, undergo biotransformation in the gut by the gut microbiota (GM) [3], now considered an essential ‘organ’ that contributes to the health status or, when altered (dysbiosis), to the onset and progression of diseases in humans [4][5]. The GM contains more than 1000 bacterial species and, to a lesser extent, viruses and archaea that participate in maintaining host homeostasis, in regulating digestion, metabolism, and immunity, and in the protection against pathogens [4]. Accumulating evidence indicates that GM composition can be modulated by dietary polyphenols, thus highlighting a two-way interaction between dietary polyphenols and GM in which host characteristics (sex, age, genetics and ethnicity) and external environmental factors (diet, lifestyle, antibiotics and drugs) can influence each other through complex mechanisms not yet fully elucidated [5][6].
However, although several data evidence that consumption of an EVOO-rich Mediterranean diet can have positive effects on GM and associated microbial metabolites [2][7], only a few human studies have evaluated the effect of EVOO polyphenols on the intestinal homeostasis. Additionally, the increasing awareness that sex (i.e., the sum of biological attributes such as chromosomes, gene expression, hormone levels, and function) and gender (i.e., the socially constructed roles, behaviors, lifestyle, expressions and identities strongly influenced by sociocultural factors) [8] influence body homeostasis and disease susceptibility [9], along with the interindividual variability in response to polyphenols intake [10], strongly suggests a sex/gender-specific approach in moving toward a science-based personalized nutrition.

2. EVOO Composition and Characteristics

Extra virgin olive oil is universally recognized as a symbol of the Mediterranean diet, and its effects on human health have been amply demonstrated by recent relevant intervention studies [11][12][13][14].
The credit for the beneficial properties of EVOO is due to its composition; EVOO contains high levels of monounsaturated acids (63–83%), mainly oleic acid, associated with a lower cardiovascular risk, and other valuable components such as phenols, phytosterols, tocopherols, and squalene, which albeit present in low percentages (1–2%) exert beneficial effects on health [15].
The lipid profile, a well-balanced ω6/ω3 ratio, and the presence of bioactive compounds have been linked to protective effects on coronary, autoimmune, and inflammatory disorders, as well as anti-thrombotic and regulatory effects of blood pressure [16].
From the fruit of the olive tree Olea europaea L., family Oleaceae, an oil is produced in which more than 30 hydrophilic phenolic compounds have been identified that contribute to the oil’s distinctive characteristic smell and flavor [17]. However, the content of these compounds depends on several factors, such as the olive cultivar, the stage of ripeness, certain environmental factors related to soil and cultivation practices, extraction conditions (heating, addition of water, and extraction systems used to separate the oil from the olive paste), and storage methods [18][19].
The cultivar, i.e., the variety of the olive, is the main differentiating factor in the quality of oils. Each cultivar has a specific organoleptic profile characterized by aromatic substances, number and contents of polyphenols, and specific composition of sterols [20]. Each cultivar also records differences in fatty acid composition. Furthermore, the production process of EVOO strongly influences the polyphenol content. Thus, this process plays a key role in the quality of the final product, giving final EVOO products with different concentrations of polyphenols ranging between 50 and 1000 mg/kg [16], most commonly between 100 and 300 mg/kg [21].

2.1. EVOO Polyphenols

Polyphenols are organic compounds that have aroused great interest for nutritional issues in recent decades. Several classes of polyphenols can be identified, namely, flavonoids, phenolic acids, phenolic alcohols, stilbenes and lignans, which differ in their chemical structure [22]. The classes of polyphenols are contained in different percentages in foods of plant origin, including EVOO [23].
In EVOO, the most abundant class is represented by secoiridoids that are present exclusively in plants belonging to the Oleaceae family and include oleuropein and ligstroside, as well as several isomers of oleuropein and ligstroside aglycons, such as the dialdehydic form of decarboxymethyl oleuropein aglycone (oleacein) and the dialdehydic form of decarboxymethyl ligstroside aglycone (oleocanthal). Lignans represent, after secoiridoids, another abundant class of phenolic compounds in EVOO; the most common representatives are pinoresinol and 1-acetoxypinoresinol. Another relevant class is that of phenolic acids, namely, hydroxybenzoic acid derivatives (such as gallic and protocatechuic acids) and hydroxycinnamic acid derivatives (such as caffeic and coumaric acids), and phenyl-alcohols, such as HT and tyrosol (Tyr). Flavonoids, luteolin and apigenin, are present in much lower levels than other phenols [24][25][26][27][28][29][30].

2.2. EVOO Polyphenols and Health

The scientific literature has provided evidence that polyphenols in EVOO contribute to the maintenance of human health by modulating metabolic processes, immune function, and cell proliferation [31][32]. The biological activity of polyphenols is strongly related to their antioxidant and anti-inflammatory properties, since they can improve the activity of the endogenous antioxidant system, reduce the pool of reactive oxygen species (ROS), neutralize potentially carcinogenic metabolites, and counteract the inflammatory processes associated with the onset of several pathological conditions [33][34][35]. For all these reasons, polyphenols, particularly EVOO polyphenols, have been considered as preventive and/or therapeutic agents against noncommunicable diseases (NCDs), such as CVD, type 2 diabetes, neurodegenerative disorders, and cancer, as well as obesity, a main risk factor for NCDs [31][32][36].
Several biological activities of polyphenols are closely linked to the antioxidant action they can exert at the level of cells and organs of the body. Oxidative stress, in fact, represents a common factor in the pathogenesis of several diseases [31][37][38]. However, emerging results suggest several mechanisms of action of EVOO polyphenols against oxidative stress that go beyond the conventional and direct free-radical-scavenging properties. In fact, EVOO polyphenols appear to be able to interact with cellular signals and influence gene expression, inducing an endogenous response to oxidative stress driven by modulation of different enzymatic activities [39][40].
Several studies have demonstrated that EVOO polyphenols are able to interact with the human immune system, influencing both the proliferation and the activity of lymphocytes and monocytes regulating the balance between anti- and pro-inflammatory cytokines, thus playing a role in inflammatory process control [41]. In particular, it has been suggested that the polyphenolic compounds in EVOO, once metabolized, can counteract the local and systemic inflammatory environment typical of immune-mediated inflammatory diseases) [33][42][43][44].

2.3. Biological Properties and Mechanisms of Action of Main EVOO Polyphenols in Preclinical Models

Among the EVOO polyphenols HT, Tyr, oleuropein, and oleocanthal have attracted great interest as a number of studies in preclinical models have demonstrated their protective power in various diseases including cardiovascular [27][45] and metabolic diseases [46].

3. Bioavailability of Polyphenols and the Two-Way Interaction with Gut Microbiota

Polyphenols contained in foods are generally conjugated with sugars or organic acids or are present as unconjugated oligomers. Following their ingestion, small amounts of polyphenols (about 5–10%) [47], mainly those with simple monomeric and dimeric structures, may be absorbed in the small intestine, via hydrolyzation of glycosides [22]. More complex polyphenols, especially with oligomeric and polymeric structures, cannot be absorbed in the small intestine; they, thus, reach the colon, where their structures are extensively modified. In particular, the intestinal microbiota first hydrolyzes glycosides into aglycones and then metabolizes them to simple phenolic acids [48][49]. Colon bacteria substantially contribute to the biotransformation of the polyphenols, breaking down unabsorbed compounds into a wide range of metabolites. Bacteria may also further modify enterocyte-derived metabolites [50].
This activity is of great importance for the biological action of these compounds, since it produces active metabolites. Prior to passage into the blood stream, the polyphenols, which are now simple aglycones, undergo conjugation processes [51]. Conjugation includes three different processes: methylation, sulfation, and glucuronidation. Then, polyphenols are distributed to organs and excreted into the urine [52].
Therefore, it is clear that the polyphenols are extensively modified after their ingestion, and any single polyphenol can generate several metabolites [53]; all these modifications deeply affect their biological activity [54][55]. It must be taken into account that the bioactive compounds present in cells and tissues are chemically, biologically, and functionally different from the ingested form.
Many studies suggest a two-way interaction between dietary polyphenols and the gut microbiota. It is well known that the GM has several important roles in normal human physiology. The composition of GM can be influenced by a multitude of environmental and lifestyle factors, among which diet [56][57][58], giving rise to dysbiosis, could play a key role in human disease progression.
Dietary polyphenols have been evidenced in numerous reports with health-promoting functions, but it has to be underlined that their beneficial effects are related to their bioavailability, which is dictated by the composition of the gut microbiota. Recent improvements in deep sequencing technologies and bioinformatics have enabled a more complex understanding of the reciprocal interactions of dietary polyphenols and gut microbiota, as well as their metabolic impact. This two-way interaction gives rise to two different phenomena. First, as previously described, the GM is able to metabolize polyphenols, yielding many active metabolites [59][60][61]. Polyphenols and their metabolites may act on metabolic pathways and confer health benefits [62][63]. Accordingly, the possible beneficial effects of polyphenols are related not only to their dietary intake, but also to the individual capacity of metabolizing them [61], clearly highlighting that a different composition of the GM will cause a different biotransformation of dietary polyphenols.
On the other hand, polyphenols may directly modulate the gut microbiota. Recent studies suggest a prebiotic-like effect of polyphenols. Prebiotics are defined as substrates selectively utilized by the host’s microorganisms, resulting in benefits for metabolic health, gastrointestinal system, bone health, and mental health [64]. Polyphenols are indeed able to stimulate the growth of beneficial bacteria, such as the genera Lactobacillus spp. (Firmicutes phylum), Bifidobacterium spp., Akkermansia spp., Roseburia spp. and Faecalibacterium spp., which provide antipathogenic and anti-inflammatory effects and cardiovascular protection [65][66]. Moreover, they are also able to hamper the increase in pathogenic bacteria, such as Clostridium spp. (Firmicutes phylum) [67][68]. Human in vivo studies have confirmed that polyphenols are able to remarkably shift the ratio between beneficial and harmful bacteria in gut microbiota, increasing the beneficial bacterial strains [69][70].
In this context, EVOO and its phenolic compounds, acting as prebiotics, can stimulate the growth of beneficial bacteria, increase the production of microbial-produced SCFAs, and reduce the abundance of pathogenic bacteria [7]. Specifically, EVOO ingestion enhances the growth of Lactobacillus and Bifidobacterium, which are also SCFA-producing bacteria, associated with potential anti-obesity effects in humans [71][72].


  1. EFSA Panel on Dietetic Products. Panel Scientific Opinion on the substantiation of health claims related to polyphenols in olive and protection of LDL particles from oxidative damage. EFSA J. 2011, 9, 2033.
  2. Finicelli, M.; Squillaro, T.; Galderisi, U.; Peluso, G. Polyphenols, the Healthy Brand of Olive Oil: Insights and Perspectives. Nutrients 2021, 13, 3831.
  3. Martin-Pelaez, S.; Castaner, O.; Sola, R.; Motilva, M.J.; Castell, M.; Perez-Cano, F.J.; Fito, M. Influence of Phenol-Enriched Olive Oils on Human Intestinal Immune Function. Nutrients 2016, 8, 213.
  4. Fan, Y.; Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 2021, 19, 55–71.
  5. Li, X.; Liu, L.; Cao, Z.; Li, W.; Li, H.; Lu, C.; Yang, X.; Liu, Y. Gut microbiota as an “invisible organ” that modulates the function of drugs. Biomed. Pharmacother. 2020, 121, 109653.
  6. Rowland, I.; Gibson, G.; Heinken, A.; Scott, K.; Swann, J.; Thiele, I.; Tuohy, K. Gut microbiota functions: Metabolism of nutrients and other food components. Eur. J. Nutr. 2018, 57, 1–24.
  7. Millman, J.F.; Okamoto, S.; Teruya, T.; Uema, T.; Ikematsu, S.; Shimabukuro, M.; Masuzaki, H. Extra-virgin olive oil and the gut-brain axis: Influence on gut microbiota, mucosal immunity, and cardiometabolic and cognitive health. Nutr. Rev. 2021, 79, 1362–1374.
  8. Biskup, E.; Marra, A.M.; Ambrosino, I.; Barbagelata, E.; Basili, S.; de Graaf, J.; Gonzalvez-Gasch, A.; Kaaja, R.; Karlafti, E.; Lotan, D.; et al. Awareness of sex and gender dimensions among physicians: The European federation of internal medicine assessment of gender differences in Europe (EFIM-IMAGINE) survey. Intern. Emerg. Med. 2022, 17, 1395–1404.
  9. Mauvais-Jarvis, F.; Bairey Merz, N.; Barnes, P.J.; Brinton, R.D.; Carrero, J.J.; DeMeo, D.L.; De Vries, G.J.; Epperson, C.N.; Govindan, R.; Klein, S.L.; et al. Sex and gender: Modifiers of health, disease, and medicine. Lancet 2020, 396, 565–582.
  10. Morand, C.; De Roos, B.; Garcia-Conesa, M.T.; Gibney, E.R.; Landberg, R.; Manach, C.; Milenkovic, D.; Rodriguez-Mateos, A.; Van de Wiele, T.; Tomas-Barberan, F. Why interindividual variation in response to consumption of plant food bioactives matters for future personalised nutrition. Proc. Nutr. Soc. 2020, 79, 225–235.
  11. Foshati, S.; Ghanizadeh, A.; Akhlaghi, M. The effect of extra virgin olive oil on anthropometric indices, lipid profile, and markers of oxidative stress and inflammation in patients with depression, a double-blind randomised controlled trial. Int. J. Clin. Pract. 2021, 75, e14254.
  12. Longhi, R.; Santos, A.; Lopez-Yerena, A.; Rodrigues, A.P.S.; Oliveira, C.; Silveira, E.A. The Effectiveness of Extra Virgin Olive Oil and the Traditional Brazilian Diet in Reducing the Inflammatory Profile of Individuals with Severe Obesity: A Randomized Clinical Trial. Nutrients 2021, 13, 4139.
  13. Podadera-Herreros, A.; Alcala-Diaz, J.F.; Gutierrez-Mariscal, F.M.; Jimenez-Torres, J.; Cruz-Ares, S.; Arenas-de Larriva, A.P.; Cardelo, M.P.; Torres-Pena, J.D.; Luque, R.M.; Ordovas, J.M.; et al. Long-term consumption of a mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: The CORDIOPREV randomized controlled trial. Clin. Nutr. 2022, 41, 552–559.
  14. Dominguez-Lopez, I.; Arancibia-Riveros, C.; Casas, R.; Tresserra-Rimbau, A.; Razquin, C.; Martinez-Gonzalez, M.A.; Hu, F.B.; Ros, E.; Fito, M.; Estruch, R.; et al. Changes in plasma total saturated fatty acids and palmitic acid are related to pro-inflammatory molecule IL-6 concentrations after nutritional intervention for one year. Biomed. Pharmacother. 2022, 150, 113028.
  15. Martinez-Gonzalez, M.A.; Ros, E.; Estruch, R. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. N. Engl. J. Med. 2018, 379, 1388–1389.
  16. Jimenez-Lopez, C.; Carpena, M.; Lourenco-Lopes, C.; Gallardo-Gomez, M.; Lorenzo, J.M.; Barba, F.J.; Prieto, M.A.; Simal-Gandara, J. Bioactive Compounds and Quality of Extra Virgin Olive Oil. Foods 2020, 9, 1014.
  17. Ben Salem, R.; Rigane, G.; Arslan, D. Phenolic substances isolated from Olea europaea L.: A Review. J. Appl. Biochem. 2015, 108, 189–213.
  18. Hachicha Hbaieb, R.; Kotti, F.; Garcia-Rodriguez, R.; Gargouri, M.; Sanz, C.; Perez, A.G. Monitoring endogenous enzymes during olive fruit ripening and storage: Correlation with virgin olive oil phenolic profiles. Food Chem. 2015, 174, 240–247.
  19. Kalua, C.M.; Bedgood, D.R.; Bishop, A.G., Jr.; Prenzler, P.D. Changes in volatile and phenolic compounds with malaxation time and temperature during virgin olive oil production. J. Agric. Food Chem. 2006, 54, 7641–7651.
  20. Jukic Spika, M.; Perica, S.; Zanetic, M.; Skevin, D. Virgin Olive Oil Phenols, Fatty Acid Composition and Sensory Profile: Can Cultivar Overpower Environmental and Ripening Effect? Antioxidants 2021, 10, 689.
  21. Criado-Navarro, I.; Lopez-Bascon, M.A.; Priego-Capote, F. Evaluating the Variability in the Phenolic Concentration of Extra Virgin Olive Oil According to the Commission Regulation (EU) 432/2012 Health Claim. J. Agric. Food Chem. 2020, 68, 9070–9080.
  22. D’Archivio, M.; Filesi, C.; Vari, R.; Scazzocchio, B.; Masella, R. Bioavailability of the polyphenols: Status and controversies. Int. J. Mol. Sci. 2010, 11, 1321–1342.
  23. Cianciosi, D.; Forbes-Hernandez, T.Y.; Afrin, S.; Gasparrini, M.; Reboredo-Rodriguez, P.; Manna, P.P.; Zhang, J.; Bravo Lamas, L.; Martinez Florez, S.; Agudo Toyos, P.; et al. Phenolic Compounds in Honey and Their Associated Health Benefits: A Review. Molecules 2018, 23, 2322.
  24. Serreli, G.; Deiana, M. Biological Relevance of Extra Virgin Olive Oil Polyphenols Metabolites. Antioxidants 2018, 7, 170.
  25. Martin-Pelaez, S.; Covas, M.I.; Fito, M.; Kusar, A.; Pravst, I. Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims. Mol. Nutr. Food Res. 2013, 57, 760–771.
  26. Hernaez, A.; Remaley, A.T.; Farras, M.; Fernandez-Castillejo, S.; Subirana, I.; Schroder, H.; Fernandez-Mampel, M.; Munoz-Aguayo, D.; Sampson, M.; Sola, R.; et al. Olive Oil Polyphenols Decrease LDL Concentrations and LDL Atherogenicity in Men in a Randomized Controlled Trial. J. Nutr. 2015, 145, 1692–1697.
  27. Souza, P.A.L.; Marcadenti, A.; Portal, V.L. Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease. Nutrients 2017, 9, 1087.
  28. Carrasco-Pancorbo, A.; Gomez-Caravaca, A.M.; Cerretani, L.; Bendini, A.; Segura-Carretero, A.; Fernandez-Gutierrez, A. A simple and rapid electrophoretic method to characterize simple phenols, lignans, complex phenols, phenolic acids, and flavonoids in extra-virgin olive oil. J. Sep. Sci. 2006, 29, 2221–2233.
  29. Servili, M.; Selvaggini, R.; Esposto, S.; Taticchi, A.; Montedoro, G.; Morozzi, G. Health and sensory properties of virgin olive oil hydrophilic phenols: Agronomic and technological aspects of production that affect their occurrence in the oil. J. Chromatogr. A 2004, 1054, 113–127.
  30. Esposito Salsano, J.; Digiacomo, M.; Cuffaro, D.; Bertini, S.; Macchia, M. Content Variations in Oleocanthalic Acid and Other Phenolic Compounds in Extra-Virgin Olive Oil during Storage. Foods 2022, 11, 1354.
  31. Reboredo-Rodriguez, P.; Varela-Lopez, A.; Forbes-Hernandez, T.Y.; Gasparrini, M.; Afrin, S.; Cianciosi, D.; Zhang, J.; Manna, P.P.; Bompadre, S.; Quiles, J.L.; et al. Phenolic Compounds Isolated from Olive Oil as Nutraceutical Tools for the Prevention and Management of Cancer and Cardiovascular Diseases. Int. J. Mol. Sci. 2018, 19, 2305.
  32. Guasch-Ferré, M.; Merino, J.; Sun, Q.; Fitó, M.; Salas-Salvadó, J. Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence. Oxid. Med. Cell. Longev. 2017, 2017, 6723931.
  33. Santangelo, C.; Vari, R.; Scazzocchio, B.; De Sanctis, P.; Giovannini, C.; D’Archivio, M.; Masella, R. Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases? Endocr. Metab. Immune Disord. Drug Targets 2018, 18, 36–50.
  34. Gorzynik-Debicka, M.; Przychodzen, P.; Cappello, F.; Kuban-Jankowska, A.; Marino Gammazza, A.; Knap, N.; Wozniak, M.; Gorska-Ponikowska, M. Potential Health Benefits of Olive Oil and Plant Polyphenols. Int. J. Mol. Sci. 2018, 19, 686.
  35. Visioli, F.; De La Lastra, C.A.; Andres-Lacueva, C.; Aviram, M.; Calhau, C.; Cassano, A.; D’Archivio, M.; Faria, A.; Fave, G.; Fogliano, V.; et al. Polyphenols and human health: A prospectus. Crit. Rev. Food Sci. Nutr. 2011, 51, 524–546.
  36. Estruch, R.; Martinez-Gonzalez, M.A.; Corella, D.; Salas-Salvado, J.; Fito, M.; Chiva-Blanch, G.; Fiol, M.; Gomez-Gracia, E.; Aros, F.; Lapetra, J.; et al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: A prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 2019, 7, e6–e17.
  37. Cordero, J.G.; Garcia-Escudero, R.; Avila, J.; Gargini, R.; Garcia-Escudero, V. Benefit of Oleuropein Aglycone for Alzheimer’s Disease by Promoting Autophagy. Oxid. Med. Cell Longev. 2018, 2018, 5010741.
  38. Hornedo-Ortega, R.; Cerezo, A.B.; de Pablos, R.M.; Krisa, S.; Richard, T.; Garcia-Parrilla, M.C.; Troncoso, A.M. Phenolic Compounds Characteristic of the Mediterranean Diet in Mitigating Microglia-Mediated Neuroinflammation. Front. Cell Neurosci. 2018, 12, 373.
  39. Masella, R.; Di Benedetto, R.; Vari, R.; Filesi, C.; Giovannini, C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 2005, 16, 577–586.
  40. Serreli, G.; Deiana, M. Extra Virgin Olive Oil Polyphenols: Modulation of Cellular Pathways Related to Oxidant Species and Inflammation in Aging. Cells 2020, 9, 478.
  41. Singh, A.; Holvoet, S.; Mercenier, A. Dietary polyphenols in the prevention and treatment of allergic diseases. Clin. Exp. Allergy 2011, 41, 1346–1359.
  42. Gambino, C.M.; Accardi, G.; Aiello, A.; Candore, G.; Dara-Guccione, G.; Mirisola, M.; Procopio, A.; Taormina, G.; Caruso, C. Effect of Extra Virgin Olive Oil and Table Olives on the ImmuneInflammatory Responses: Potential Clinical Applications. Endocr. Metab. Immune Disord. Drug Targets 2018, 18, 14–22.
  43. Casas, R.; Estruch, R.; Sacanella, E. The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses. Endocr. Metab. Immune Disord. Drug Targets 2018, 18, 23–35.
  44. Del Corno, M.; Varano, B.; Scazzocchio, B.; Filesi, C.; Masella, R.; Gessani, S. Protocatechuic acid inhibits human dendritic cell functional activation: Role of PPARgamma up-modulation. Immunobiology 2014, 219, 416–424.
  45. Tripoli, E.; Giammanco, M.; Tabacchi, G.; Di Majo, D.; Giammanco, S.; La Guardia, M. The phenolic compounds of olive oil: Structure, biological activity and beneficial effects on human health. Nutr. Res. Rev. 2005, 18, 98–112.
  46. Santangelo, C.; Filesi, C.; Vari, R.; Scazzocchio, B.; Filardi, T.; Fogliano, V.; D’Archivio, M.; Giovannini, C.; Lenzi, A.; Morano, S.; et al. Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: A possible involvement of reduced levels of circulating visfatin. J. Endocrinol. Invest. 2016, 39, 1295–1301.
  47. Correa, T.A.F.; Rogero, M.M.; Hassimotto, N.M.A.; Lajolo, F.M. The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. Front. Nutr. 2019, 6, 188.
  48. Kuhnau, J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev. Nutr. Diet 1976, 24, 117–191.
  49. Chen, L.; Cao, H.; Xiao, J. Polyphenols: Absorption, bioavailability, and metabolomics. In Polyphenols: Properties, Recovery, and Applications; Galanakis, C.M., Ed.; Woodhead Publishing: Sawston, UK, 2018; pp. 45–67.
  50. Cardona, F.; Andres-Lacueva, C.; Tulipani, S.; Tinahones, F.J.; Queipo-Ortuno, M.I. Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 2013, 24, 1415–1422.
  51. Felgines, C.; Talavera, S.; Texier, O.; Gil-Izquierdo, A.; Lamaison, J.L.; Remesy, C. Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans. J. Agric. Food Chem. 2005, 53, 7721–7727.
  52. Williamson, G.; Clifford, M.N. Role of the small intestine, colon and microbiota in determining the metabolic fate of polyphenols. Biochem. Pharmacol. 2017, 139, 24–39.
  53. Porrini, M.; Riso, P. Factors influencing the bioavailability of antioxidants in foods: A critical appraisal. Nutr. Metab. Cardiovasc. Dis. 2008, 18, 647–650.
  54. Kawabata, K.; Yoshioka, Y.; Terao, J. Role of Intestinal Microbiota in the Bioavailability and Physiological Functions of Dietary Polyphenols. Molecules 2019, 24, 370.
  55. Del Rio, D.; Costa, L.G.; Lean, M.E.J.; Crozier, A. Polyphenols and health: What compounds are involved? Nutr. Metab. Cardiovasc. Dis. 2010, 20, 1–6.
  56. Flandroy, L.; Poutahidis, T.; Berg, G.; Clarke, G.; Dao, M.C.; Decaestecker, E.; Furman, E.; Haahtela, T.; Massart, S.; Plovier, H.; et al. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci. Total Environ. 2018, 627, 1018–1038.
  57. Gentile, C.L.; Weir, T.L. The gut microbiota at the intersection of diet and human health. Science 2018, 362, 776–780.
  58. Rothschild, D.; Weissbrod, O.; Barkan, E.; Kurilshikov, A.; Korem, T.; Zeevi, D.; Costea, P.I.; Godneva, A.; Kalka, I.N.; Bar, N.; et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 2018, 555, 210–215.
  59. Danneskiold-Samsoe, N.B.; Dias de Freitas Queiroz Barros, H.; Santos, R.; Bicas, J.L.; Cazarin, C.B.B.; Madsen, L.; Kristiansen, K. Pastore GM, Brix S, Marostica Junior MR: Interplay between food and gut microbiota in health and disease. Food Res. Int. 2019, 115, 23–31.
  60. Eid, H.M.; Wright, M.L.; Anil Kumar, N.V.; Qawasmeh, A.; Hassan, S.T.S.; Mocan, A.; Nabavi, S.M.; Rastrelli, L.; Atanasov, A.G.; Haddad, P.S. Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food Ingredients. Front. Pharmacol. 2017, 8, 387.
  61. Scazzocchio, B.; Minghetti, L.; D’Archivio, M. Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of Curcumin. Nutrients 2020, 12, 2499.
  62. Anhe, F.F.; Nachbar, R.T.; Varin, T.V.; Trottier, J.; Dudonne, S.; Le Barz, M.; Feutry, P.; Pilon, G.; Barbier, O.; Desjardins, Y.; et al. Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice. Gut 2019, 68, 453–464.
  63. Van Hul, M.; Cani, P.D. Targeting Carbohydrates and Polyphenols for a Healthy Microbiome and Healthy Weight. Curr. Nutr. Rep. 2019, 8, 307–316.
  64. Molinari, R.; Merendino, N.; Costantini, L. Polyphenols as modulators of pre-established gut microbiota dysbiosis: State-of-the-art. Biofactors 2022, 48, 255–273.
  65. Alves-Santos, A.M.; Sugizaki, C.S.A.; Lima, G.C.; Naves, M.M.V. Prebiotic effect of dietary polyphenols: A systematic review. J. Funct. Foods 2020, 74, 104169.
  66. Tomova, A.; Bukovsky, I.; Rembert, E.; Yonas, W.; Alwarith, J.; Barnard, N.D.; Kahleova, H. The Effects of Vegetarian and Vegan Diets on Gut Microbiota. Front. Nutr. 2019, 6, 47.
  67. Krga, I.; Milenkovic, D. Anthocyanins: From Sources and Bioavailability to Cardiovascular-Health Benefits and Molecular Mechanisms of Action. J. Agric. Food Chem. 2019, 67, 1771–1783.
  68. Ozdal, T.; Sela, D.A.; Xiao, J.; Boyacioglu, D.; Chen, F.; Capanoglu, E. The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility. Nutrients 2016, 8, 78.
  69. Peterson, C.T.; Vaughn, A.R.; Sharma, V.; Chopra, D.; Mills, P.J.; Peterson, S.N.; Sivamani, R.K. Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study. J. Evid. Based Integr. Med. 2018, 23, 2515690X18790725.
  70. Peron, G.; Sut, S.; Dal Ben, S.; Voinovich, D.; Dall’Acqua, S. Untargeted UPLC-MS metabolomics reveals multiple changes of urine composition in healthy adult volunteers after consumption of curcuma longa L. extract. Food Res. Int. 2020, 127, 108730.
  71. Farras, M.; Martinez-Gili, L.; Portune, K.; Arranz, S.; Frost, G.; Tondo, M.; Blanco-Vaca, F. Modulation of the Gut Microbiota by Olive Oil Phenolic Compounds: Implications for Lipid Metabolism, Immune System, and Obesity. Nutrients 2020, 12, 2200.
  72. Luisi, M.L.E.; Lucarini, L.; Biffi, B.; Rafanelli, E.; Pietramellara, G.; Durante, M.; Vidali, S.; Provensi, G.; Madiai, S.; Gheri, C.F.; et al. Effect of Mediterranean Diet Enriched in High Quality Extra Virgin Olive Oil on Oxidative Stress, Inflammation and Gut Microbiota in Obese and Normal Weight Adult Subjects. Front. Pharmacol. 2019, 10, 1366.
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : , , , , ,
View Times: 242
Revisions: 2 times (View History)
Update Date: 14 Sep 2022